Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$572M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$495M |
| 3 |
iShares MBS ETF
MBB
|
+$405M |
| 4 |
Procter & Gamble
PG
|
+$365M |
| 5 |
Microsoft
MSFT
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$605M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$544M |
| 3 |
Sempra
SRE
|
+$474M |
| 4 |
CELG
Celgene Corp
CELG
|
+$411M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$380M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.85% |
| 2 | Healthcare | 5.77% |
| 3 | Financials | 5.26% |
| 4 | Consumer Discretionary | 4.71% |
| 5 | Communication Services | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SPNE
4651
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $299K | ﹤0.01% |
+24,885
| New | +$304K |
|
|
XENT
4652
CALL
DELISTED
Intersect ENT, Inc
XENT
| $299K | ﹤0.01% |
12,000
-83,000
| -87% | -$1.68M |
|
4653
ADMA Biologics
ADMA
$2.03B
| $298K | ﹤0.01% |
74,700
-353,887
| -83% | -$1.54M |
|
4654
iShares MSCI BIC ETF
BKF
$78.3M
| $297K | ﹤0.01% |
6,555
| – | – |
|
4655
Merchants Bancorp
MBIN
$2.56B
| $297K | ﹤0.01% |
22,587
+12,997
| +136% | +$152K |
|
4656
Construction Partners
ROAD
$6.11B
| $297K | ﹤0.01% |
17,598
+10,669
| +154% | +$187K |
|
4657
CALL
Invesco CurrencyShares Canadian Dollar Trust
FXC
$69.5M
| $296K | ﹤0.01% |
3,900
-2,000
| -34% | -$150K |
|
4658
PUT
Ovintiv
OVV
$17.1B
| $296K | ﹤0.01% |
12,640
-138,000
| -92% | -$2.96M |
|
|
CEO
4659
DELISTED
CNOOC Limited
CEO
| $296K | ﹤0.01% |
1,775
-8,191
| -82% | -$1.25M |
|
|
MCBC
4660
DELISTED
Macatawa Bank Corp
MCBC
| $295K | ﹤0.01% |
26,501
+13,267
| +100% | +$141K |
|
4661
CALL
iShares MSCI Hong Kong ETF
EWH
$1.23B
| $294K | ﹤0.01% |
12,100
-146,900
| -92% | -$3.47M |
|
4662
Investar Holding Corp
ISTR
$415M
| $294K | ﹤0.01% |
12,270
+4,870
| +66% | +$120K |
|
4663
PUT
Invesco DB US Dollar Index Bullish Fund
UUP
$424M
| $293K | ﹤0.01% |
11,300
-42,100
| -79% | -$1.13M |
|
|
TGP
4664
PUT
DELISTED
Teekay LNG Partners L.P.
TGP
| $293K | ﹤0.01% |
18,800
+3,200
| +21% | +$47.2K |
|
4665
Dianthus Therapeutics
DNTH
$5.8B
| $292K | ﹤0.01% |
1,205
+572
| +90% | +$107K |
|
4666
PUT
Trane Technologies
TT
$101B
| $292K | ﹤0.01% |
2,200
-1,300
| -37% | -$165K |
|
|
ERF
4667
DELISTED
Enerplus Corporation
ERF
| $292K | ﹤0.01% |
40,946
-23,306
| -36% | -$152K |
|
4668
Vanguard Total World Stock ETF
VT
$78B
| $291K | ﹤0.01% |
3,597
| – | – |
|
|
GNC
4669
DELISTED
GNC Holdings, Inc.
GNC
| $291K | ﹤0.01% |
107,977
+36,278
| +51% | +$96.9K |
|
4670
MasterCraft Boat Holdings
MCFT
$582M
| $290K | ﹤0.01% |
18,406
-4,740
| -20% | -$74.7K |
|
4671
Tiptree Inc
TIPT
$658M
| $290K | ﹤0.01% |
35,655
+12,963
| +57% | +$99.1K |
|
4672
BCB Bancorp
BCBP
$170M
| $289K | ﹤0.01% |
20,944
+13,821
| +194% | +$184K |
|
4673
CALL
Canadian National Railway
CNI
$76.1B
| $289K | ﹤0.01% |
3,200
+1,100
| +52% | +$98.9K |
|
4674
National Bankshares
NKSH
$262M
| $289K | ﹤0.01% |
6,437
+3,223
| +100% | +$138K |
|
|
GLUU
4675
PUT
DELISTED
Glu Mobile Inc.
GLUU
| $289K | ﹤0.01% |
47,800
-3,100
| -6% | -$17.7K |
|
Similar funds
Barclays's Q4 2019 Portfolio in Review
As of Q4 2019, Barclays held 7,254 positions worth $180B, up 13% from $160B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Barclays deployed $6.1B of net new capital in Q4 2019, opening 260 new positions and adding to 3,541 existing holdings. Its largest new stake was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
By sector, the portfolio is most concentrated in Technology at 8.9% of assets, up from 7.7% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $605M trimmed.
- Barclays's largest Q4 2019 buy was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
- Barclays added most to Apple in Q4 2019, an estimated $572M increase.
- Barclays's biggest Q4 2019 reduction was Invesco QQQ Trust, cutting an estimated $605M.
- Barclays fully exited Celgene Corp in Q4 2019, selling an estimated $411M.
- Barclays's ten largest holdings make up 26% of its $180B portfolio in Q4 2019.
- Barclays opened 260 new positions and closed 700 in Q4 2019.
- Barclays's portfolio value rose 13% quarter-over-quarter to $180B.
Based on Barclays's 13F filing for Q4 2019, filed 10 Feb 2020.